Granules India: December ’22 Results Update
Moneylife Digital Team 27 January 2023
Granules India (Granules) continues to report healthy numbers y-o-y (year-on-year). We had earlier covered Granules in detail here. In Q3FY22-23, revenue was up by 15% y-o-y to Rs1,146 crore, driven by strong demand in paracetamol. With supply issues far behind with regard to its raw material, PAP (para-amino phenol), the plant is running at full capacity. As a result, Granules’ customers are...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Get access to complete archives
Rs 5000 + GST
Already a subscriber ? Log in
Polycab: December ’22 Results Update
Moneylife Digital Team 25 January 2023
Polycab reported gross quarterly revenue of Rs3,715 crore, up 11.5% quarter-on-quarter (q-o-q) and 10.17% year-on-year (y-o-y). Operating profit was Rs503 crore—up 17.8% q-o-q and 38.95% y-o-y—and net profit was Rs361 crore—up...
Free Helpline
Legal Credit